The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Regenerative Medicine Market Research Report 2022

Global Regenerative Medicine Market Research Report 2022

Publishing Date : Jun, 2022

License Type :
 

Report Code : 1419073

No of Pages : 110

Synopsis

Market Analysis and Insights: Global Regenerative Medicine Market
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.
Regenerative medicine is defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function and has been called the "next evolution of medical treatments" and “the vanguard of 21st century healthcare” by the U.S. Department of Health and Human Services.

The global Regenerative Medicine market size is projected to reach US$ 115660 million by 2028, from US$ 33370 million in 2021, at a CAGR of 19.2% during 2022-2028.
Global Regenerative Medicine key players include J & J (DePuy Synthes), Medtronic, Allergan(Acelity), Zimmer Biomet, etc. Global top four manufacturers hold a share about 10%.
North America is the largest market, with a share about 25%, followed by Europe, and Asia Pacific, both have a share over 40 percent.
In terms of product, Tissue Engineering is the largest segment, with a share over 40%. And in terms of application, the largest application is Dermatology, followed by Cardiovascular, CNS, Orthopedic, etc.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Regenerative Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Regenerative Medicine market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Regenerative Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Regenerative Medicine market.

Global Regenerative Medicine Scope and Market Size
Regenerative Medicine market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Regenerative Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Cell Therapy
  • Tissue Engineering
  • Biomaterial
  • Other

Segment by Application

  • Dermatology
  • Cardiovascular
  • CNS
  • Orthopedic
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia) 
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • J & J (DePuy Synthes)
  • Medtronic
  • Zimmer Biomet
  • Stryker
  • Allergan(Acelity)
  • MiMedx Group
  • Organogenesis
  • Fujifilm Cellular Dynamics
  • Osiris Therapeutics
  • Vcanbio
  • CCBC
  • Cytori
  • Celgene
  • Vericel Corporation
  • Guanhao Biotech
  • Mesoblast
  • AMAG Pharmaceuticals (CBR)
  • ViaCord
  • CordLife
  • Integra LifeSciences
  • Nuvasive
  • Cook Biotech
  • Japan Tissue Engineering
Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regenerative Medicine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Biomaterial
1.2.5 Other
1.3 Market by Application
1.3.1 Global Regenerative Medicine Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Dermatology
1.3.3 Cardiovascular
1.3.4 CNS
1.3.5 Orthopedic
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Regenerative Medicine Market Perspective (2017-2028)
2.2 Regenerative Medicine Growth Trends by Region
2.2.1 Regenerative Medicine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Regenerative Medicine Historic Market Size by Region (2017-2022)
2.2.3 Regenerative Medicine Forecasted Market Size by Region (2023-2028)
2.3 Regenerative Medicine Market Dynamics
2.3.1 Regenerative Medicine Industry Trends
2.3.2 Regenerative Medicine Market Drivers
2.3.3 Regenerative Medicine Market Challenges
2.3.4 Regenerative Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Regenerative Medicine Players by Revenue
3.1.1 Global Top Regenerative Medicine Players by Revenue (2017-2022)
3.1.2 Global Regenerative Medicine Revenue Market Share by Players (2017-2022)
3.2 Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Regenerative Medicine Revenue
3.4 Global Regenerative Medicine Market Concentration Ratio
3.4.1 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regenerative Medicine Revenue in 2021
3.5 Regenerative Medicine Key Players Head office and Area Served
3.6 Key Players Regenerative Medicine Product Solution and Service
3.7 Date of Enter into Regenerative Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Regenerative Medicine Breakdown Data by Type
4.1 Global Regenerative Medicine Historic Market Size by Type (2017-2022)
4.2 Global Regenerative Medicine Forecasted Market Size by Type (2023-2028)
5 Regenerative Medicine Breakdown Data by Application
5.1 Global Regenerative Medicine Historic Market Size by Application (2017-2022)
5.2 Global Regenerative Medicine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Regenerative Medicine Market Size (2017-2028)
6.2 North America Regenerative Medicine Market Size by Country (2017-2022)
6.3 North America Regenerative Medicine Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Regenerative Medicine Market Size (2017-2028)
7.2 Europe Regenerative Medicine Market Size by Country (2017-2022)
7.3 Europe Regenerative Medicine Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Regenerative Medicine Market Size (2017-2028)
8.2 Asia-Pacific Regenerative Medicine Market Size by Country (2017-2022)
8.3 Asia-Pacific Regenerative Medicine Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Regenerative Medicine Market Size (2017-2028)
9.2 Latin America Regenerative Medicine Market Size by Country (2017-2022)
9.3 Latin America Regenerative Medicine Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Regenerative Medicine Market Size (2017-2028)
10.2 Middle East & Africa Regenerative Medicine Market Size by Country (2017-2022)
10.3 Middle East & Africa Regenerative Medicine Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 J & J (DePuy Synthes)
11.1.1 J & J (DePuy Synthes) Company Detail
11.1.2 J & J (DePuy Synthes) Business Overview
11.1.3 J & J (DePuy Synthes) Regenerative Medicine Introduction
11.1.4 J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2017-2022)
11.1.5 J & J (DePuy Synthes) Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Detail
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Regenerative Medicine Introduction
11.2.4 Medtronic Revenue in Regenerative Medicine Business (2017-2022)
11.2.5 Medtronic Recent Development
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Detail
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Regenerative Medicine Introduction
11.3.4 Zimmer Biomet Revenue in Regenerative Medicine Business (2017-2022)
11.3.5 Zimmer Biomet Recent Development
11.4 Stryker
11.4.1 Stryker Company Detail
11.4.2 Stryker Business Overview
11.4.3 Stryker Regenerative Medicine Introduction
11.4.4 Stryker Revenue in Regenerative Medicine Business (2017-2022)
11.4.5 Stryker Recent Development
11.5 Allergan(Acelity)
11.5.1 Allergan(Acelity) Company Detail
11.5.2 Allergan(Acelity) Business Overview
11.5.3 Allergan(Acelity) Regenerative Medicine Introduction
11.5.4 Allergan(Acelity) Revenue in Regenerative Medicine Business (2017-2022)
11.5.5 Allergan(Acelity) Recent Development
11.6 MiMedx Group
11.6.1 MiMedx Group Company Detail
11.6.2 MiMedx Group Business Overview
11.6.3 MiMedx Group Regenerative Medicine Introduction
11.6.4 MiMedx Group Revenue in Regenerative Medicine Business (2017-2022)
11.6.5 MiMedx Group Recent Development
11.7 Organogenesis
11.7.1 Organogenesis Company Detail
11.7.2 Organogenesis Business Overview
11.7.3 Organogenesis Regenerative Medicine Introduction
11.7.4 Organogenesis Revenue in Regenerative Medicine Business (2017-2022)
11.7.5 Organogenesis Recent Development
11.8 Fujifilm Cellular Dynamics
11.8.1 Fujifilm Cellular Dynamics Company Detail
11.8.2 Fujifilm Cellular Dynamics Business Overview
11.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Introduction
11.8.4 Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2017-2022)
11.8.5 Fujifilm Cellular Dynamics Recent Development
11.9 Osiris Therapeutics
11.9.1 Osiris Therapeutics Company Detail
11.9.2 Osiris Therapeutics Business Overview
11.9.3 Osiris Therapeutics Regenerative Medicine Introduction
11.9.4 Osiris Therapeutics Revenue in Regenerative Medicine Business (2017-2022)
11.9.5 Osiris Therapeutics Recent Development
11.10 Vcanbio
11.10.1 Vcanbio Company Detail
11.10.2 Vcanbio Business Overview
11.10.3 Vcanbio Regenerative Medicine Introduction
11.10.4 Vcanbio Revenue in Regenerative Medicine Business (2017-2022)
11.10.5 Vcanbio Recent Development
11.11 CCBC
11.11.1 CCBC Company Detail
11.11.2 CCBC Business Overview
11.11.3 CCBC Regenerative Medicine Introduction
11.11.4 CCBC Revenue in Regenerative Medicine Business (2017-2022)
11.11.5 CCBC Recent Development
11.12 Cytori
11.12.1 Cytori Company Detail
11.12.2 Cytori Business Overview
11.12.3 Cytori Regenerative Medicine Introduction
11.12.4 Cytori Revenue in Regenerative Medicine Business (2017-2022)
11.12.5 Cytori Recent Development
11.13 Celgene
11.13.1 Celgene Company Detail
11.13.2 Celgene Business Overview
11.13.3 Celgene Regenerative Medicine Introduction
11.13.4 Celgene Revenue in Regenerative Medicine Business (2017-2022)
11.13.5 Celgene Recent Development
11.14 Vericel Corporation
11.14.1 Vericel Corporation Company Detail
11.14.2 Vericel Corporation Business Overview
11.14.3 Vericel Corporation Regenerative Medicine Introduction
11.14.4 Vericel Corporation Revenue in Regenerative Medicine Business (2017-2022)
11.14.5 Vericel Corporation Recent Development
11.15 Guanhao Biotech
11.15.1 Guanhao Biotech Company Detail
11.15.2 Guanhao Biotech Business Overview
11.15.3 Guanhao Biotech Regenerative Medicine Introduction
11.15.4 Guanhao Biotech Revenue in Regenerative Medicine Business (2017-2022)
11.15.5 Guanhao Biotech Recent Development
11.16 Mesoblast
11.16.1 Mesoblast Company Detail
11.16.2 Mesoblast Business Overview
11.16.3 Mesoblast Regenerative Medicine Introduction
11.16.4 Mesoblast Revenue in Regenerative Medicine Business (2017-2022)
11.16.5 Mesoblast Recent Development
11.17 AMAG Pharmaceuticals (CBR)
11.17.1 AMAG Pharmaceuticals (CBR) Company Detail
11.17.2 AMAG Pharmaceuticals (CBR) Business Overview
11.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Introduction
11.17.4 AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2017-2022)
11.17.5 AMAG Pharmaceuticals (CBR) Recent Development
11.18 ViaCord
11.18.1 ViaCord Company Detail
11.18.2 ViaCord Business Overview
11.18.3 ViaCord Regenerative Medicine Introduction
11.18.4 ViaCord Revenue in Regenerative Medicine Business (2017-2022)
11.18.5 ViaCord Recent Development
11.19 CordLife
11.19.1 CordLife Company Detail
11.19.2 CordLife Business Overview
11.19.3 CordLife Regenerative Medicine Introduction
11.19.4 CordLife Revenue in Regenerative Medicine Business (2017-2022)
11.19.5 CordLife Recent Development
11.20 Integra LifeSciences
11.20.1 Integra LifeSciences Company Detail
11.20.2 Integra LifeSciences Business Overview
11.20.3 Integra LifeSciences Regenerative Medicine Introduction
11.20.4 Integra LifeSciences Revenue in Regenerative Medicine Business (2017-2022)
11.20.5 Integra LifeSciences Recent Development
11.21 Nuvasive
11.21.1 Nuvasive Company Detail
11.21.2 Nuvasive Business Overview
11.21.3 Nuvasive Regenerative Medicine Introduction
11.21.4 Nuvasive Revenue in Regenerative Medicine Business (2017-2022)
11.21.5 Nuvasive Recent Development
11.22 Cook Biotech
11.22.1 Cook Biotech Company Detail
11.22.2 Cook Biotech Business Overview
11.22.3 Cook Biotech Regenerative Medicine Introduction
11.22.4 Cook Biotech Revenue in Regenerative Medicine Business (2017-2022)
11.22.5 Cook Biotech Recent Development
11.23 Japan Tissue Engineering
11.23.1 Japan Tissue Engineering Company Detail
11.23.2 Japan Tissue Engineering Business Overview
11.23.3 Japan Tissue Engineering Regenerative Medicine Introduction
11.23.4 Japan Tissue Engineering Revenue in Regenerative Medicine Business (2017-2022)
11.23.5 Japan Tissue Engineering Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Regenerative Medicine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Tissue Engineering
Table 4. Key Players of Biomaterial
Table 5. Key Players of Other
Table 6. Global Regenerative Medicine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Regenerative Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Regenerative Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Regenerative Medicine Market Share by Region (2017-2022)
Table 10. Global Regenerative Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Regenerative Medicine Market Share by Region (2023-2028)
Table 12. Regenerative Medicine Market Trends
Table 13. Regenerative Medicine Market Drivers
Table 14. Regenerative Medicine Market Challenges
Table 15. Regenerative Medicine Market Restraints
Table 16. Global Regenerative Medicine Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Regenerative Medicine Market Share by Players (2017-2022)
Table 18. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2021)
Table 19. Ranking of Global Top Regenerative Medicine Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Regenerative Medicine Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Regenerative Medicine Product Solution and Service
Table 23. Date of Enter into Regenerative Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Regenerative Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Regenerative Medicine Revenue Market Share by Type (2017-2022)
Table 27. Global Regenerative Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Regenerative Medicine Revenue Market Share by Type (2023-2028)
Table 29. Global Regenerative Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Regenerative Medicine Revenue Market Share by Application (2017-2022)
Table 31. Global Regenerative Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Regenerative Medicine Revenue Market Share by Application (2023-2028)
Table 33. North America Regenerative Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Regenerative Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Regenerative Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Regenerative Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Regenerative Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Regenerative Medicine Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Regenerative Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Regenerative Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Regenerative Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Regenerative Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 43. J & J (DePuy Synthes) Company Detail
Table 44. J & J (DePuy Synthes) Business Overview
Table 45. J & J (DePuy Synthes) Regenerative Medicine Product
Table 46. J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 47. J & J (DePuy Synthes) Recent Development
Table 48. Medtronic Company Detail
Table 49. Medtronic Business Overview
Table 50. Medtronic Regenerative Medicine Product
Table 51. Medtronic Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 52. Medtronic Recent Development
Table 53. Zimmer Biomet Company Detail
Table 54. Zimmer Biomet Business Overview
Table 55. Zimmer Biomet Regenerative Medicine Product
Table 56. Zimmer Biomet Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 57. Zimmer Biomet Recent Development
Table 58. Stryker Company Detail
Table 59. Stryker Business Overview
Table 60. Stryker Regenerative Medicine Product
Table 61. Stryker Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 62. Stryker Recent Development
Table 63. Allergan(Acelity) Company Detail
Table 64. Allergan(Acelity) Business Overview
Table 65. Allergan(Acelity) Regenerative Medicine Product
Table 66. Allergan(Acelity) Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 67. Allergan(Acelity) Recent Development
Table 68. MiMedx Group Company Detail
Table 69. MiMedx Group Business Overview
Table 70. MiMedx Group Regenerative Medicine Product
Table 71. MiMedx Group Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 72. MiMedx Group Recent Development
Table 73. Organogenesis Company Detail
Table 74. Organogenesis Business Overview
Table 75. Organogenesis Regenerative Medicine Product
Table 76. Organogenesis Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 77. Organogenesis Recent Development
Table 78. Fujifilm Cellular Dynamics Company Detail
Table 79. Fujifilm Cellular Dynamics Business Overview
Table 80. Fujifilm Cellular Dynamics Regenerative Medicine Product
Table 81. Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 82. Fujifilm Cellular Dynamics Recent Development
Table 83. Osiris Therapeutics Company Detail
Table 84. Osiris Therapeutics Business Overview
Table 85. Osiris Therapeutics Regenerative Medicine Product
Table 86. Osiris Therapeutics Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 87. Osiris Therapeutics Recent Development
Table 88. Vcanbio Company Detail
Table 89. Vcanbio Business Overview
Table 90. Vcanbio Regenerative Medicine Product
Table 91. Vcanbio Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 92. Vcanbio Recent Development
Table 93. CCBC Company Detail
Table 94. CCBC Business Overview
Table 95. CCBC Regenerative MedicineProduct
Table 96. CCBC Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 97. CCBC Recent Development
Table 98. Cytori Company Detail
Table 99. Cytori Business Overview
Table 100. Cytori Regenerative MedicineProduct
Table 101. Cytori Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 102. Cytori Recent Development
Table 103. Celgene Company Detail
Table 104. Celgene Business Overview
Table 105. Celgene Regenerative MedicineProduct
Table 106. Celgene Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 107. Celgene Recent Development
Table 108. Vericel Corporation Company Detail
Table 109. Vericel Corporation Business Overview
Table 110. Vericel Corporation Regenerative MedicineProduct
Table 111. Vericel Corporation Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 112. Vericel Corporation Recent Development
Table 113. Guanhao Biotech Company Detail
Table 114. Guanhao Biotech Business Overview
Table 115. Guanhao Biotech Regenerative MedicineProduct
Table 116. Guanhao Biotech Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 117. Guanhao Biotech Recent Development
Table 118. Mesoblast Company Detail
Table 119. Mesoblast Business Overview
Table 120. Mesoblast Regenerative MedicineProduct
Table 121. Mesoblast Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 122. Mesoblast Recent Development
Table 123. AMAG Pharmaceuticals (CBR) Company Detail
Table 124. AMAG Pharmaceuticals (CBR) Business Overview
Table 125. AMAG Pharmaceuticals (CBR) Regenerative MedicineProduct
Table 126. AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 127. AMAG Pharmaceuticals (CBR) Recent Development
Table 128. ViaCord Company Detail
Table 129. ViaCord Business Overview
Table 130. ViaCord Regenerative MedicineProduct
Table 131. ViaCord Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 132. ViaCord Recent Development
Table 133. CordLife Company Detail
Table 134. CordLife Business Overview
Table 135. CordLife Regenerative MedicineProduct
Table 136. CordLife Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 137. CordLife Recent Development
Table 138. Integra LifeSciences Company Detail
Table 139. Integra LifeSciences Business Overview
Table 140. Integra LifeSciences Regenerative MedicineProduct
Table 141. Integra LifeSciences Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 142. Integra LifeSciences Recent Development
Table 143. Nuvasive Company Detail
Table 144. Nuvasive Business Overview
Table 145. Nuvasive Regenerative MedicineProduct
Table 146. Nuvasive Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 147. Nuvasive Recent Development
Table 148. Cook Biotech Company Detail
Table 149. Cook Biotech Business Overview
Table 150. Cook Biotech Regenerative MedicineProduct
Table 151. Cook Biotech Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 152. Cook Biotech Recent Development
Table 153. Japan Tissue Engineering Company Detail
Table 154. Japan Tissue Engineering Business Overview
Table 155. Japan Tissue Engineering Regenerative MedicineProduct
Table 156. Japan Tissue Engineering Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 157. Japan Tissue Engineering Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Regenerative Medicine Market Share by Type: 2021 VS 2028
Figure 2. Cell Therapy Features
Figure 3. Tissue Engineering Features
Figure 4. Biomaterial Features
Figure 5. Other Features
Figure 6. Global Regenerative Medicine Market Share by Application in 2021 & 2028
Figure 7. Dermatology Case Studies
Figure 8. Cardiovascular Case Studies
Figure 9. CNS Case Studies
Figure 10. Orthopedic Case Studies
Figure 11. Others Case Studies
Figure 12. Regenerative Medicine Report Years Considered
Figure 13. Global Regenerative Medicine Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Regenerative Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Regenerative Medicine Market Share by Region: 2021 VS 2028
Figure 16. Global Regenerative Medicine Market Share by Players in 2021
Figure 17. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Regenerative Medicine Revenue in 2021
Figure 19. North America Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America Regenerative Medicine Market Share by Country (2017-2028)
Figure 21. United States Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Regenerative Medicine Market Share by Country (2017-2028)
Figure 25. Germany Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Regenerative Medicine Market Share by Region (2017-2028)
Figure 33. China Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Regenerative Medicine Market Share by Country (2017-2028)
Figure 41. Mexico Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Regenerative Medicine Market Share by Country (2017-2028)
Figure 45. Turkey Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. J & J (DePuy Synthes) Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 48. Medtronic Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 49. Zimmer Biomet Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 50. Stryker Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 51. Allergan(Acelity) Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 52. MiMedx Group Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 53. Organogenesis Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 54. Fujifilm Cellular Dynamics Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 55. Osiris Therapeutics Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 56. Vcanbio Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 57. CCBC Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 58. Cytori Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 59. Celgene Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 60. Vericel Corporation Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 61. Guanhao Biotech Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 62. Mesoblast Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 63. AMAG Pharmaceuticals (CBR) Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 64. ViaCord Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 65. CordLife Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 66. Integra LifeSciences Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 67. Nuvasive Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 68. Cook Biotech Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 69. Japan Tissue Engineering Revenue Growth Rate in Regenerative Medicine Business (2017-2022)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’